282 related items for PubMed ID: 17615501
1. [A multicenter, open-label, randomized comparison of suppressive effects on asthmatic inflammation of lower airways and improved effects on health-related QOL between HFA-BDP and fluticasone propionate].
Ohbayashi H, Adachi M, Ichinose M, Ohta K, Kokubu F, Sano Y, Tamura G, Tohda Y, Hirata K, Yasuba H.
Arerugi; 2007 Jun; 56(6):577-86. PubMed ID: 17615501
[Abstract] [Full Text] [Related]
2. Hydrofluoroalkane-beclomethasone dipropionate effectively improves airway eosinophilic inflammation including the distal airways of patients with mild to moderate persistent asthma as compared with fluticasone propionate in a randomized open double-cross study.
Ohbayashi H, Adachi M.
Allergol Int; 2008 Sep; 57(3):231-9. PubMed ID: 18493166
[Abstract] [Full Text] [Related]
3. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation].
Ohbayashi H.
Arerugi; 2005 Jan; 54(1):24-35. PubMed ID: 15841673
[Abstract] [Full Text] [Related]
4. One-year evaluation of the preventative effect of hydrofluoroalkane-beclomethasone dipropionate on eosinophilic inflammation of asthmatic peripheral airways.
Ohbayashi H.
Respiration; 2007 Jan; 74(2):146-53. PubMed ID: 16804291
[Abstract] [Full Text] [Related]
5. Efficacy of HFA-beclomethasone dipropionate extra-fine aerosol (800 microg day(-1)) versus HFA-fluticasone propionate (1000 microg day(-1)) in patients with asthma.
Aubier M, Wettenger R, Gans SJ.
Respir Med; 2001 Mar; 95(3):212-20. PubMed ID: 11266239
[Abstract] [Full Text] [Related]
6. Usefulness of HFA-BDP for adult patients with bronchial asthma: randomized crossover study with fluticasone.
Horiguchi T, Hayashi N, Ohira D, Torigoe H, Ito T, Hirose M, Sasaki Y, Shiga M, Miyazaki J, Kondo R, Tachikawa S.
J Asthma; 2006 Sep; 43(7):509-12. PubMed ID: 16939990
[Abstract] [Full Text] [Related]
7. Step-down therapy with low-dose fluticasone-salmeterol combination or medium-dose hydrofluoroalkane 134a-beclomethasone alone.
Fowler SJ, Currie GP, Lipworth BJ.
J Allergy Clin Immunol; 2002 Jun; 109(6):929-35. PubMed ID: 12063520
[Abstract] [Full Text] [Related]
8. Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children.
Lasserson TJ, Cates CJ, Jones AB, Steele EH, White J.
Cochrane Database Syst Rev; 2005 Oct 19; (4):CD005309. PubMed ID: 16235400
[Abstract] [Full Text] [Related]
9. Short-term lower leg growth in 5- to 11-year-old asthmatic children using beclomethasone dipropionate inhalers with chlorofluorocarbon or hydrofluoroalkane propellants: a 9-week, open-label, randomized, crossover, noninferiority study.
Wolthers OD, Walters EG.
Clin Ther; 2011 Aug 19; 33(8):1069-76. PubMed ID: 21784529
[Abstract] [Full Text] [Related]
10. Effects of hydrofluoroalkane and dry powder-formulated corticosteroids on sputum inflammatory markers in asthmatic patients.
Hauber H, Taha R, Bergeron C, Migounov V, Hamid Q, Olivenstein R.
Can Respir J; 2006 Mar 19; 13(2):73-8. PubMed ID: 16550263
[Abstract] [Full Text] [Related]
11. Efficacy of beclomethasone dipropionate HFA 200 microg once daily in chronic obstructive pulmonary disease and bronchial asthma.
Tatsis G, Kotsifas K, Filaditaki V, Makrantoni G, Boulia S.
J Int Med Res; 2007 Mar 19; 35(3):361-73. PubMed ID: 17593865
[Abstract] [Full Text] [Related]
12. Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children.
Lasserson TJ, Cates CK, Jones AB, Steele EH, White J.
Cochrane Database Syst Rev; 2006 Apr 19; 2006(2):CD005309. PubMed ID: 16625634
[Abstract] [Full Text] [Related]
13. Characterization of respiratory deposition of fluticasone-salmeterol hydrofluoroalkane-134a and hydrofluoroalkane-134a beclomethasone in asthmatic patients.
Leach CL, Kuehl PJ, Chand R, Ketai L, Norenberg JP, McDonald JD.
Ann Allergy Asthma Immunol; 2012 Mar 19; 108(3):195-200. PubMed ID: 22374204
[Abstract] [Full Text] [Related]
14. Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma.
Thongngarm T, Silkoff PE, Kossack WS, Nelson HS.
J Asthma; 2005 May 19; 42(4):257-63. PubMed ID: 16032934
[Abstract] [Full Text] [Related]
15. Influence of dentures on residual inhaled corticosteroids in the mouths of elderly asthma patients.
Ohbayashi H, Adachi M.
Respir Investig; 2012 Jun 19; 50(2):54-61. PubMed ID: 22749251
[Abstract] [Full Text] [Related]
16. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA, Rooklin A, Schoaf L, Scott C, Ellsworth A, House K, Dorinsky P.
Clin Ther; 2006 Jan 19; 28(1):73-85. PubMed ID: 16490581
[Abstract] [Full Text] [Related]
17. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
Juniper EF, Buist AS.
Chest; 1999 Nov 19; 116(5):1297-303. PubMed ID: 10559091
[Abstract] [Full Text] [Related]
18. Real life clinical study design supporting the effectiveness of extra-fine inhaled beclomethasone/formoterol at the level of small airways of asthmatics.
Popov TA, Petrova D, Kralimarkova TZ, Ivanov Y, Popova T, Peneva M, Odzhakova T, Ilieva Y, Yakovliev P, Lazarova T, Georgiev O, Hodzhev V, Hodzheva E, Staevska MT, Dimitrov VD.
Pulm Pharmacol Ther; 2013 Dec 19; 26(6):624-9. PubMed ID: 23769863
[Abstract] [Full Text] [Related]
19. Long-term safety and efficacy of a chlorofluorocarbon-free beclomethasone dipropionate extrafine aerosol.
Fireman P, Prenner BM, Vincken W, Demedts M, Mol SJ, Cohen RM.
Ann Allergy Asthma Immunol; 2001 May 19; 86(5):557-65. PubMed ID: 11379808
[Abstract] [Full Text] [Related]
20. Dose-response for adrenal suppression with hydrofluoroalkane formulations of fluticasone propionate and beclomethasone dipropionate.
Fowler SJ, Orr LC, Wilson AM, Sims EJ, Lipworth BJ.
Br J Clin Pharmacol; 2001 Jul 19; 52(1):93-5. PubMed ID: 11453895
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
